— Know what they know.
Not Investment Advice

AGARWALEYE.NS

Dr. Agarwal's Health Care Limited
1W: -2.5% 1M: -6.8% 3M: -20.8% YTD: -8.8% 1Y: +5.3%
₹416.45 ($4.42)
+0.75 (+0.18%)
 
NSE · Healthcare · Medical - Instruments & Supplies · ₹131.7B · Alpha Radar Sell · Power 34
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹131.7B ($1.4B)
52W Range327-568
Volume81,037
Avg Volume167,344
Beta0.64
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOAdil Agarwal
Employees4,214
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2025-02-04
3rd Floor, Buhari Towers
Chennai 600006
IN
91 44 4378 7777
About Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms